Last reviewed · How we verify
Micronutrients
Micronutrients is a Small molecule drug developed by Phoenix VA Health Care System. It is currently in Phase 1 development. Also known as: ZnSO4, Vitamin B50, Ergocalciferol, & Thiamin Hydrochloride.
Micronutrients are essential chemicals required by organisms in small quantities to perform various biogeochemical processes and regulate physiological functions of cells and organs. They support the health of organisms throughout life by enabling these processes, and examples of micronutrients include B vitamins and folic acid, which have been studied in clinical trials for conditions such as anemia and iron deficiency anemia.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Micronutrients |
|---|---|
| Also known as | ZnSO4, Vitamin B50, Ergocalciferol, & Thiamin Hydrochloride |
| Sponsor | Phoenix VA Health Care System |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania (NA)
- Phenylalanine-free Diet for Patients With Secondary Hyperphenylalaninemia in ICU (NA)
- Choline to Improve Malnutrition and Enhance Cognition (NA)
- Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention (NA)
- Child Health, Agriculture and Integrated Nutrition (NA)
- Impact of CRRT on Serum Carnitine and Micronutrient Levels
- Effects of Complementary Feeding of Eggs on Infant Development and Growth in Guatemala: The Saqmolo Study (NA)
- Folic Acid Salt Study (FISFA Zambia) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Micronutrients CI brief — competitive landscape report
- Micronutrients updates RSS · CI watch RSS
- Phoenix VA Health Care System portfolio CI
Frequently asked questions about Micronutrients
What is Micronutrients?
Who makes Micronutrients?
Is Micronutrients also known as anything else?
What development phase is Micronutrients in?
Related
- Manufacturer: Phoenix VA Health Care System — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: ZnSO4, Vitamin B50, Ergocalciferol, & Thiamin Hydrochloride
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing